National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
 View Search Criteria | Help With Results
           

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase III
Treatment
Active
Not specified
Other
2003/081/HP
NCT00213655

Last Modified: 4/17/2008     First Published: 7/7/2006  

2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase III
Treatment
Active
18 and over
Other
CAN-NCIC-BL11
NCT00352079, BL11


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase III
Treatment
Active
Not specified
Pharmaceutical / Industry
102.1
NCT00384891


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Diagnostic, Treatment
Active
No age specified
Other
A/100/0601
NCT00298298


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Active
18 and over
Other
CC/ORI 07-02
NCT00671554

Last Modified: 6/12/2008     First Published: 8/3/2007  

6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
NCI
NCI-07-C-0188
07-C-0188, NCT00514072


7.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Approved-not yet active
18 and over
Pharmaceutical / Industry
CR-60/9150
NCT00694915

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov